The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Open accessAbstract
The adenosine class of heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiological processes and is antagonized by caffeine. We have determined the crystal structure of the human A 2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resolution. Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helices relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally determined GPCRs. The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane. The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Self-citationInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationCrystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,930
The Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,344
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
Self-citationRequirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin
Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., & Khorana, H. G. (1996) · Science · doi:10.1126/science.274.5288.768 · Cited by 1,179
The Retinal Conformation and its Environment in Rhodopsin in Light of a New 2.2 Å Crystal Structure
Okada, T., Sugihara, M., Bondar, A.-N., Elstner, M., Entel, P., & Buss, V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.044 · Cited by 1,049
Hanson, M. A., Cherezov, V., Griffith, M. T., Roth, C. B., Jaakola, V.-P., Chien, E. Y. T., Velasquez, J., Kuhn, P., & Stevens, R. C. (2008) · Structure · doi:10.1016/j.str.2008.05.001 · Cited by 933
Self-citationA meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
The G protein-coupled receptor repertoires of human and mouse
Vassilatis, D. K., Hohmann, J. G., Zeng, H., Li, F., Ranchalis, J. E., Mortrud, M. T., Brown, A., Rodriguez, S. S., Weller, J. R., Wright, A. C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230374100 · Cited by 790
Conformational complexity of G-protein-coupled receptors
Kobilka, B. K., & Deupi, X. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.003 · Cited by 694
Adenosine and sleep–wake regulation
Basheer, R., Strecker, R. E., Thakkar, M. M., & McCarley, R. W. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.004 · Cited by 587
Crystal structure of squid rhodopsin
Murakami, M., & Kouyama, T. (2008) · Nature · doi:10.1038/nature06925 · Cited by 488
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
During, M. J., & Spencer, D. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320504 · Cited by 476
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440
Targeting adenosine A2A receptors in Parkinson's disease
Schwarzschild, M. A., Agnati, L., Fuxe, K., Chen, J.-F., & Morelli, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.004 · Cited by 433
Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form
Serrano-Vega, M. J., Magnani, F., Shibata, Y., & Tate, C. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711253105 · Cited by 422
Poucher, S. M., Keddie, J. R., Singh, P., Stoggall, S. M., Caulkett, P. W. R., Jones, G., & Collis, M. G. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15923.x · Cited by 363
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J.-F., Masino, S. A., & Vaugeois, J.-M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 354
Adenosine in the spinal cord and periphery: release and regulation of pain
Sawynok, J., & Liu, X. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00050-9 · Cited by 353
Novel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bezard, E., Brotchie, J., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Novère, N. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 298
Joost, P., & Methner, A. (2002) · Genome Biology · doi:10.1186/gb-2002-3-11-research0063 · Cited by 219
Co-evolving stability and conformational homogeneity of the human adenosine A2areceptor
Magnani, F., Shibata, Y., Serrano-Vega, M. J., & Tate, C. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804396105 · Cited by 214
Kim, J., Wess, J., van Rhee, A. M., Schöneberg, T., & Jacobson, K. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13987 · Cited by 209
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
Ongini, E., Dionisotti, S., Gessi, S., Irenius, E., & Fredholm, B. B. (1999) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005326 · Cited by 187
Vogel, R., Mahalingam, M., Lüdeke, S., Huber, T., Siebert, F., & Sakmar, T. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.022 · Cited by 164
Adenosine receptors and asthma
Brown, R. A., Spina, D., & Page, C. P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.22 · Cited by 152
Adenosine A1-A2A receptor heteromers: New targets for caffeine in the brain
Ferre, S. (2008) · Frontiers in bioscience · doi:10.2741/2852 · Cited by 149
2-Amino-6-furan-2-yl-4-substituted Nicotinonitriles as A2A Adenosine Receptor Antagonists
Mantri, M., de Graaf, O., van Veldhoven, J., Göblyös, A., Künzel, J. K. V. F. D., Mulder‐Krieger, T., Link, R., de Vries, H., Beukers, M. W., Brussee, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701594y · Cited by 149
Self-citationAdenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
Blum, D. L., Hourez, R., Galas, M., Popoli, P., & Schiffmann, S. N. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00411-3 · Cited by 149
Kim, J. S., Jiang, Q., Glashofer, M., Yehle, S., Wess, J., & Jacobson, K. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08783-8 · Cited by 119
Burstein, E. S., Spalding, T. A., & Brann, M. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24322 · Cited by 119
Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions
Gao, Z., & IJzerman, A. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00360-9 · Cited by 106
Self-citationBenarroch, E. E. (2008) · Neurology · doi:10.1212/01.wnl.0000297939.18236.ec · Cited by 96
Shi, Y., Liu, X., Gebremedhin, D., Falck, J. R., Harder, D. R., & Koehler, R. C. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600511 · Cited by 91
Insights into signaling from the β2-adrenergic receptor structure
Audet, M., & Bouvier, M. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.97 · Cited by 90
The A2A‐adenosine receptor: a GPCR with unique features?
Zezula, J., & Freissmuth, M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707674 · Cited by 88
Jiang, Q., Lee, B. X., Glashofer, M., van Rhee, A. M., & Jacobson, K. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970084v · Cited by 66
G protein-coupled receptors show unusual patterns of intrinsic unfolding
Jaakola, V., Prilusky, J., Sussman, J. L., & Goldman, A. (2005) · Protein Engineering Design and Selection · doi:10.1093/protein/gzi004 · Cited by 51
Self-citationMoro, S., Deflorian, F., Spalluto, G., Pastorin, G., Cacciari, B., Kim, S., & Jacobson, K. A. (2003) · Chemical Communications · doi:10.1039/b303439a · Cited by 45
Molecular modeling of adenosine receptors: new results and trends
Martinelli, A., & Tuccinardi, T. (2008) · Medicinal research reviews (Print) · doi:10.1002/med.20106 · Cited by 40
Scholl, D. J., & Wells, J. N. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00474-3 · Cited by 39
Purines, the carotid body and respiration
Lahiri, S., Mitchell, C. H., Reigada, D., Roy, A., & Cherniack, N. S. (2007) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2007.02.015 · Cited by 34
Yuzlenko, O., & Kieć‐Kononowicz, K. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.21001 · Cited by 30
D’Haeze, W. (2002) · Genome biology · doi:10.1186/gb-2002-3-12-reports0063 · Cited by 8
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
Chemistry and Biology Of Multicomponent Reactions
Dömling, A., Wang, W., & Wang, K. (2012) · Chemical Reviews · doi:10.1021/cr100233r · Cited by 2,547
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Self-citationStructure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Metadata
- Authors
- Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C.
- Venue
- Science
- Published
- 2008-11-21
- Volume
- 322
- Issue
- 5905
- Pages
- 1211-1217
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1975740938
- Cited by
- 1,781
- References
- 48
- FWCI
- 78.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.